ArticleBMC biotechnology2006
Conditional gene expression in the mouse using a Sleeping Beauty gene-trap transposon.
Article in BMC biotechnology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 37 citations in OpenAlex.
- Transposons As Tools for Functional Genomics in Vertebrate Models.Trends in genetics : TIG · 2017Review
- Prokaryotic expression and purification of soluble goldfish Tgf2 transposase with transposition activity.Molecular biotechnology · 2015Article
- Cocaine self-administration in rats lacking a functional trpc4 gene.F1000Research · 2013Article
- High-throughput phenotyping of avoidance learning in mice discriminates different genotypes and identifies a novel gene.Genes, brain, and behavior · 2012Article
- Article
- Remobilization of Sleeping Beauty transposons in the germline of Xenopus tropicalis.Mobile DNA · 2011Article
- Somatic mutagenesis with a Sleeping Beauty transposon system leads to solid tumor formation in zebrafish.PloS one · 2011Article
- Sleeping Beauty transposon mutagenesis of the rat genome in spermatogonial stem cells.Methods (San Diego, Calif.) · 2011Article
- Large-scale analysis of the regulatory architecture of the mouse genome with a transposon-associated sensor.Nature genetics · 2011Article
- Efficient mammalian germline transgenesis by cis-enhanced Sleeping Beauty transposition.Transgenic research · 2011Article
- A transient transgenic RNAi strategy for rapid characterization of gene function during embryonic development.PloS one · 2010Article
- Article
- Gene targeting in the rat: advances and opportunities.Trends in genetics : TIG · 2010Review
- The NemaGENETAG initiative: large scale transposon insertion gene-tagging in Caenorhabditis elegans.Genetica · 2009Review
- Transposon-mediated genome manipulation in vertebrates.Nature methods · 2009Review
- Transposon mutagenesis in mice.Methods in molecular biology (Clifton, N.J.) · 2009Article
- Shielding of sleeping beauty DNA transposon-delivered transgene cassettes by heterologous insulators in early embryonal cells.Molecular therapy : the journal of the American Society of Gene Therapy · 2009Article
- Efficient transposition of the Tol2 transposable element from a single-copy donor in zebrafish.Proceedings of the National Academy of Sciences of the United States of America · 2008Article
- Enzymatic engineering of the porcine genome with transposons and recombinases.BMC biotechnology · 2007Article
- Sleeping beauty transposase has an affinity for heterochromatin conformation.Molecular and cellular biology · 2007Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundInsertional mutagenesis techniques with transposable elements have been popular among geneticists studying model organisms from E. coli to Drosophila and, more recently, the mouse. One such element is the Sleeping Beauty (SB) transposon that has been shown in several studies to be an effective insertional mutagen in the mouse germline. SB transposon vector studies have employed different functional elements and reporter molecules to disrupt and report the expression of endogenous mouse genes. We sought to generate a transposon system that would be capable of reporting the expression pattern of a mouse gene while allowing for conditional expression of a gene of interest in a tissue- or temporal-specific pattern.
resultsHere we report the systematic development and testing of a transposon-based gene-trap system incorporating the doxycycline-repressible Tet-Off (tTA) system that is capable of activating the expression of genes under control of a Tet response element (TRE) promoter. We demonstrate that the gene trap system is fully functional in vitro by introducing the "gene-trap tTA" vector into human cells by transposition and identifying clones that activate expression of a TRE-luciferase transgene in a doxycycline-dependent manner. In transgenic mice, we mobilize gene-trap tTA vectors, discover parameters that can affect germline mobilization rates, and identify candidate gene insertions to demonstrate the in vivo functionality of the vector system. We further demonstrate that the gene-trap can act as a reporter of endogenous gene expression and it can be coupled with bioluminescent imaging to identify genes with tissue-specific expression patterns.
conclusionAkin to the GAL4/UAS system used in the fly, we have made progress developing a tool for mutating and revealing the expression of mouse genes by generating the tTA transactivator in the presence of a secondary TRE-regulated reporter molecule. A vector like the gene-trap tTA could provide a means for both annotating mouse genes and creating a resource of mice that express a regulable transcription factor in temporally- and tissue-specific patterns for conditional gene expression studies. These mice would be a valuable resource to the mouse genetics community for purpose of dissecting mammalian gene function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.